Regulation And Legal
Bharat Parenterals Subsidiary Receives 5 FDA VAI Observations
Bharat Parenterals subsidiary Innoxel Lifesciences received 5 observations under Voluntary Action Indicated classification from surprise US FDA inspection.
Inspection occurred April 13-17 and 20, 2026
